Current Affairs

Stem Cell Therapy Advisory

2.2 Governance, The Hindu, 2026-09-18

The Union Health Ministry's advisory of September 16 asks States and UTs to offer stem cell therapy as standard care only for approved indications, with use for Autism Spectrum Disorder restricted to approved clinical trials under the National Guidelines for Stem Cell Research, 2017 (ICMR and DBT). It follows the January 30, 2026 Supreme Court judgment in Yash Charitable Trust v. Union of India. Violations attract action under Sections 32 and 40 of the Clinical Establishments Act, 2010. NMC's September 5 advisory deems unauthorised promotion professional misconduct.